Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS-0100 (Leucine + Metformin) in Type 2 Diabetes
NCT02151461Phase 2Completed
- Sponsor
- NuSirt Biopharma
- Start
- Jul 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of l-leucine in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by NuSirt Biopharma. Primary endpoint: Absolute Plasma Glucose Area Under the Curve (AUC) 0-3hr at Day 28. Started Jul 2014; status: completed.
02
Drugs
l-leucine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02151461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151461.